KEY
53
2
QCOM
82
2
GLW
71
2
ABBV
59
2
WBA
28
4
PRU
54
7
MCHP
58
3
WMB
67
3
AAPL
70
9
DFS
62
3
CB
46
-2
SHW
53
-6
GM
77
2
MPC
44
14
SYK
42
-13
DVN
39
3
INTC
35
3
AME
59
2
WFC
60
2
ADM
34
-2
KEY
53
2
QCOM
82
2
GLW
71
2
ABBV
59
2
WBA
28
4
PRU
54
7
MCHP
58
3
WMB
67
3
AAPL
70
9
DFS
62
3
CB
46
-2
SHW
53
-6
GM
77
2
MPC
44
14
SYK
42
-13
DVN
39
3
INTC
35
3
AME
59
2
WFC
60
2
ADM
34
-2
Financhill
Back

Eloxx Pharmaceuticals 10K Form

Sell
34

ELOX
Eloxx Pharmaceuticals

Last Price:
0.90
Seasonality Move:
-10.16%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive ELOX News And Ratings

See the #1 stock for the next 7 days that we like better than ELOX

ELOX Financial Statistics

Sales & Book Value

Annual Sales: $75K
Cash Flow: $-3.45M
Price / Cash Flow: 0
Annual Sales: $-6.53
Price / Book: 0

Profitability

EPS (TTM): -9.07000
Net Income (TTM): $-20.48M
Gross Margin: $140K
Return on Equity: 0%
Return on Assets: 0%

Eloxx Pharmaceuticals Earnings Forecast

Key Eloxx Pharmaceuticals Financial Ratios

  • The Gross Profit Margin over the past 3 years for ELOX is 100.00%.
  • The Selling, General & Administrative Expenses for ELOX have been equal to 1,882.07% of Gross Profit Margin.
  • The Interest Expense is -5.40% of Operating Income.
  • Per Share Earnings over the last 26 years have been positive in 16 years.

Eloxx Pharmaceuticals Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: OTCM
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: ELOX
CUSIP: 29014R
Website: eloxxpharma.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

ELOX Technical Analysis vs Fundamental Analysis

Sell
34
Eloxx Pharmaceuticals (ELOX) is a Sell

Is Eloxx Pharmaceuticals a Buy or a Sell?